Perrigo receives FDA approval to market mini nicotine Lozenges Perrigo announced that it has received approval from the FDA for its Abbreviated New Drug Applications to market over-the-counter nicotine polacrilex mini lozenge USP, 2 mg and 4 mg. Nicorette Mini Lozenge is selling at an annual rate estimated at over $30M at all retail outlets. The product is expected to begin shipping in the next 90 days.
News For PRGO From The Last 14 Days
Check below for free stories on PRGO the last two weeks.
Subscribe for More Information